#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Medulloblastoma Eosinophilic oesophagitis Interstitial lung disease Thrombotic thrombocytopenic purpura Leiomyosarcoma recurrent Autoinflammation with infantile enterocolitis Giant cell tumour of tendon sheath Barth syndrome Epidermolysis bullosa Rett syndrome Colitis ulcerative Hodgkin's disease refractory Postprandial hypoglycaemia Biliary cancer metastatic Hodgkin's disease More trials…

    Learn about Rare Diseases

    Tuberous sclerosis complex – Diagnostics Epidermolysis bullosa – Basic Information Synovial sarcoma recurrent Encephalitis autoimmune Wiskott-Aldrich syndrome – Diagnostics Extranodal marginal zone B-cell lymphoma (MALT type) Encephalitis autoimmune – Diagnostics Acute respiratory distress syndrome – Treatment Advanced systemic mastocytosis – Life with Disease Ornithine transcarbamoylase deficiency – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Dabigatran Regadenoson Apadamtase Alfa Mva-Hbvac Amlodipine Dolutegravir Pimecrolimus Sym025 Mr0005 Osilodrostat Minocycline Etoposide Phosphate Metformin Embonate Icosapent Ethyl Belumosudil Mesilate Ro7589655 Abc-15Bo-116 ANUMIGILIMAB Mavacamten Ertapenem More therapies…

    Learn about Your Condition

    Tendon disorder Atrial fibrillation Portal hypertension Inner ear disorder Urethral valves Aicardi-Goutieres syndrome Type 1 diabetes mellitus Pre-eclampsia Metastasis CADASIL Hypereosinophilic syndrome Sjogren's syndrome Chondrocalcinosis Leukoencephalopathy Angiosarcoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Small cell lung cancer

  • A Study of ABBV-706 to Assess Safety and Efficacy Compared with Standard Drug Combination in Adults with Relapsed or Refractory Small Cell Lung Cancer

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Topotecan
    • HUMANISED IGG1 MONOCLONAL ANTIBODY AGAINST SEZ6, CONJUGATED TO (2S)-2-(2-BROMOACETAMIDO)-N-[(2S)-1-({3-[(7S)-7-ETHYL-7-HYDROXY-8,11-DIOXO-7,8,11,13-TETRAHYDRO-2H,10H-[1,3]DIOXOLO[4,5-G]PYRANO[3′,4′:6,7]INDOLIZINO[1,2-B]QUINOLIN-14-YL]BICYCLO[1.1.1]PENTAN-1-YL}AMINO)-1-OXOPROPAN-2-YL]-3-METHYLBUTANAMIDE
    Austria Belgium France Germany Greece Italy +1

  • Safety and Tolerability of Alisertib Sodium and Paclitaxel in Patients with Small Cell Lung Cancer (Phase 2 Study)

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Small cell lung cancer
    Investigated Drugs:
    • Alisertib Sodium
    • Paclitaxel
    France Poland Spain

  • Phase 2 Study of PF-08634404 with Carboplatin and Etoposide in Adults with Untreated Small Cell Lung Cancer

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Small cell lung cancer
    Investigated Drugs:
    • Carboplatin
    • Etoposide
    France Italy Spain

  • Study on the Safety and Effectiveness of AL8326 for Patients with Small Cell Lung Cancer Needing Second-Line Treatment

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    • Renal cell carcinoma
    • Small cell lung cancer
    Investigated Drugs:
    • Al8326
    Italy Spain

  • Study on the Safety and Effectiveness of AL8326 for Patients with Small Cell Lung Cancer Needing Second-Line Treatment

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Small cell lung cancer
    Investigated Drugs:
    • Al8326
    Italy Spain

  • Study on the Use of 68Ga-EVG321 for Diagnosing Small Cell Lung Cancer in Patients

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Small cell lung cancer
    Investigated Drugs:
    • Evg321
    • Gallium (68Ga)
    Austria Germany Italy
Previous Page
1 2 3 4 5 6
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!